Glioblastoma Foundation Genomic Testing & Research Laboratory Ribbon-Cutting Ceremony on Sept. 3rd
Opening of testing lab ushers in a new era of targeted treatments to change glioblastoma diagnosis from terminal to treatable The Glioblastoma Foundation is hosting...
Nascent Biotech Regains Worldwide Rights for Pritumumab
NORTH PALM BEACH, FL / ACCESSWIRE / May 26, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company...
IQ-AI Announces Orphan Drug Designation Status
MILWAUKEE, WI / ACCESSWIRE / February 28, 2023 / IQ-AI Limited, (OTCQB:IQAIF)(LSE:IQAI), and its US-based subsidiary, Imaging Biometrics, LLC (Milwaukee, WI) is pleased to announce...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
The Glioblastoma Foundation® launched a new awareness campaign today featuring Morgan Myles as the celebrity ambassador with the goal of raising awareness of Glioblastoma —...
Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, Appointed as Board Chairman of the Glioblastoma Research Organization
- Global Advocate for Brain Cancer Research Brings a New Focus to US Efforts to Fund Glioblastoma Research -MIAMI, FL / ACCESSWIRE / February 6,...
Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trial
NORTH PALM BEACH, FL / ACCESSWIRE / January 25, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company...